MyFinsight
Home
Blog
About
Exchange differences on
translation of foreign...
$1,043K
(-83.89%↓ Y/Y)
Total comprehensive
(loss) income
$235K
(106.15%↑ Y/Y)
Net income (loss)
-$808K
(92.16%↑ Y/Y)
Net income (loss)
before income taxes
-$514K
(94.70%↑ Y/Y)
Income tax expense
$294K
(-51.49%↓ Y/Y)
Interest income
$3,582K
(-16.13%↓ Y/Y)
Other income, net
$3,070K
(-34.58%↓ Y/Y)
us-us-US
$74,937K
(16.93%↑ Y/Y)
europe-europe-Europe
$34,124K
international-international-International
$6,866K
Interest expense
$3,062K
(0.56%↑ Y/Y)
Income (loss) from
operations
-$2,996K
(79.86%↑ Y/Y)
total revenue
$115,927K
(18.34%↑ Y/Y)
Foreign currency loss
(gain)
-$1,108K
(-50.14%↓ Y/Y)
Research and development
expense
$73,945K
(7.15%↑ Y/Y)
Selling, general and
administrative expense
$43,890K
(2.57%↑ Y/Y)
Cost of revenue from
sale of therapies
$1,088K
(4.62%↑ Y/Y)
Back
Back
Income Statement
Immunocore Holdings plc (IMCR)
Immunocore Holdings plc (IMCR)
source: myfinsight.com